InsidersTradesSigma
Discover the complete record of transactions filed by DeLuca Richard R., Chief Executive Officer. Officer active across 1 companies, notably Merck & Co., Inc.. Cumulatively, 5 filings have been recorded. The latest transaction was filed on 24 February 2022 — Attribution. Regulator: SEC (Form 4). The full history is accessible without signup.
5 of 5 declarations
Richard R. DeLuca is the Executive Vice President and President of Merck Animal Health, a division of Merck & Co., Inc. He oversees the operations of this division, defining growth and innovation strategies. His leadership is essential for ensuring the success of Merck Animal Health.